M

Metagenomi Inc
NASDAQ:MGX

Watchlist Manager
Metagenomi Inc
NASDAQ:MGX
Watchlist
Price: 2.1 USD 5.53% Market Closed
Market Cap: 78.7m USD
Have any thoughts about
Metagenomi Inc?
Write Note

P/E
Price to Earnings

-1
Current
-2
Median
23.9
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-1
=
Market Cap
78.7m USD
/
Net Income
-75m USD
All Countries
Close
Earnings Growth
US
M
Metagenomi Inc
NASDAQ:MGX
Average P/E: 56.8
Negative Multiple: -1
N/A
US
Abbvie Inc
NYSE:ABBV
67.8
406%
US
Amgen Inc
NASDAQ:AMGN
55.2
74%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -250.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
105.2
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -492.1 N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
21.3
56%
AU
CSL Ltd
ASX:CSL
34.5
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -57 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -469.3 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -125.4 N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-0.7
2-Years Forward
P/E
-0.7
3-Years Forward
P/E
-1

See Also

Discover More